These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 20947502)

  • 1. Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors.
    Takata K; Kitamura Y; Saeki M; Terada M; Kagitani S; Kitamura R; Fujikawa Y; Maelicke A; Tomimoto H; Taniguchi T; Shimohama S
    J Biol Chem; 2010 Dec; 285(51):40180-91. PubMed ID: 20947502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases.
    Kawamata J; Shimohama S
    J Alzheimers Dis; 2011; 24 Suppl 2():95-109. PubMed ID: 21403387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction.
    Roberts JP; Stokoe SA; Sathler MF; Nichols RA; Kim S
    J Biol Chem; 2021; 296():100402. PubMed ID: 33571523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
    Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
    J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
    J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors.
    Nikiforuk A; Potasiewicz A; Kos T; Popik P
    Behav Brain Res; 2016 Oct; 313():214-218. PubMed ID: 27435422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system.
    Santos MD; Alkondon M; Pereira EF; Aracava Y; Eisenberg HM; Maelicke A; Albuquerque EX
    Mol Pharmacol; 2002 May; 61(5):1222-34. PubMed ID: 11961141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.
    Zhai Y; Yamashita T; Nakano Y; Sun Z; Shang J; Feng T; Morihara R; Fukui Y; Ohta Y; Hishikawa N; Abe K
    J Alzheimers Dis; 2016 Jun; 53(3):893-905. PubMed ID: 27314529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R; Marutle A; Nordberg A
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
    Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
    Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.
    Samochocki M; Höffle A; Fehrenbacher A; Jostock R; Ludwig J; Christner C; Radina M; Zerlin M; Ullmer C; Pereira EF; Lübbert H; Albuquerque EX; Maelicke A
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1024-36. PubMed ID: 12649296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early administration of galantamine from preplaque phase suppresses oxidative stress and improves cognitive behavior in APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Saito T; Hisahara S; Iwahara N; Emoto MC; Yokokawa K; Suzuki H; Manabe T; Matsumura A; Suzuki S; Matsushita T; Kawamata J; Sato-Akaba H; Fujii HG; Shimohama S
    Free Radic Biol Med; 2019 Dec; 145():20-32. PubMed ID: 31536772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S 24795 limits beta-amyloid-alpha7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies.
    Wang HY; Bakshi K; Shen C; Frankfurt M; Trocmé-Thibierge C; Morain P
    Biol Psychiatry; 2010 Mar; 67(6):522-30. PubMed ID: 19932469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
    Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors.
    Lopes C; Pereira EF; Wu HQ; Purushottamachar P; Njar V; Schwarcz R; Albuquerque EX
    J Pharmacol Exp Ther; 2007 Jul; 322(1):48-58. PubMed ID: 17446300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.
    Dajas-Bailador FA; Heimala K; Wonnacott S
    Mol Pharmacol; 2003 Nov; 64(5):1217-26. PubMed ID: 14573772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors enhance procognitive effects of conventional anti-Alzheimer drugs in scopolamine-treated rats.
    Potasiewicz A; Krawczyk M; Gzielo K; Popik P; Nikiforuk A
    Behav Brain Res; 2020 May; 385():112547. PubMed ID: 32087183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR.
    Samochocki M; Zerlin M; Jostock R; Groot Kormelink PJ; Luyten WH; Albuquerque EX; Maelicke A
    Acta Neurol Scand Suppl; 2000; 176():68-73. PubMed ID: 11261808
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.